CPIX - Cumberland Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
47,353
40,742
41,150
33,026
33,519
Cost of Revenue
8,800
7,378
7,371
5,959
4,968
Gross Profit
38,553
33,364
33,780
27,067
28,551
Operating Expenses
Research Development
6,693
7,321
3,901
3,191
3,848
Selling General and Administrative
32,840
30,664
31,523
23,115
21,602
Total Operating Expenses
43,441
40,754
37,861
28,500
27,439
Operating Income or Loss
-4,888
-7,391
-4,081
-1,433
1,112
Interest Expense
353
196
93
106
74
Total Other Income/Expenses Net
-
-
-
0
0
Income Before Tax
-4,880
-7,022
-3,875
-1,335
1,247
Income Tax Expense
-68
17
4,175
-331
576
Income from Continuing Operations
-4,811
-7,039
-8,050
-1,004
671
Net Income
-4,797
-6,963
-7,979
-945
731
Net Income available to common shareholders
-4,797
-6,963
-7,979
-945
731
Reported EPS
Basic
-
-0.45
-0.50
-0.06
0.04
Diluted
-
-0.45
-0.50
-0.06
0.04
Weighted average shares outstanding
Basic
-
15,614
15,912
16,237
16,716
Diluted
-
15,614
15,912
16,237
17,095
EBITDA
-
-3,844
-1,134
1,168
3,568